Streetbeat News

Products Services

LULU

Financial analysts have observed a bullish sentiment in the options trading for Lululemon Athletica (NASDAQ:LULU), with 58% of trades being bullish. The analysis highlighted a focus on a price range between $440.0 and $490.0 for LULU, based on unusual trading activity. The company, known for its athletic apparel and accessories, has seen its stock price increase by 1.02% to $448.0. Analyst opinions on LULU are mixed, with a downgrade from Needham to Buy at a target price of $525 and a downgrade from Exane BNP Paribas to Underperform with a target price of $415.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 6:45 pm

BZFD

DPRO

ETSY

LRHC

RIVN

Etsy shares fell by around 8% after reporting mixed Q4 financial results, missing earnings estimates but beating sales forecasts. Other stocks showed significant movements, with La Rosa Holdings, BuzzFeed, and Monopar Therapeutics among the top gainers, while Draganfly, Greenbrook TMS, and Synaptogenix led the losers. Notable movements were also seen in companies like Rivian Automotive, Lucid Group, and Sunnova Energy due to various announcements and financial results.

Portfolio Pulse from Avi Kapoor

February 22, 2024 | 6:38 pm

CRSP

Smart money investors have shown a bearish stance on CRISPR Therapeutics (NASDAQ:CRSP), with unusual options trading activity observed. Benzinga's options scanner revealed 26 significant trades, with a sentiment split of 38% bullish and 61% bearish. The trades suggest a price target range of $50.0 to $110.0 for CRSP over the next three months. The company, a leader in gene editing technology, is currently trading at $82.0, with a slight decrease of -0.5%. Its most advanced pipeline candidate, exa-cel, is in collaboration with Vertex Pharmaceuticals.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 6:15 pm

VIEW

View Inc has received a Notice of Allowance for its U.S. patent application 17/250,586, which is focused on control methods and systems using external 3D modeling and neural networks. This development could enhance View Inc's intellectual property portfolio and potentially its market position in technologies related to smart windows and glass.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 6:15 pm

MNPR

Monopar Therapeutics Inc (NASDAQ:MNPR) shares surged 67.30% to $0.95 on high volume after announcing promising preclinical data for its MNPR-101 radiopharmaceutical program targeting cancers. The program showed significant tumor uptake and near-complete tumor elimination with a single injection. Additionally, Monopar received clearance in Australia to commence a Phase 1 trial of MNPR-101-Zr in patients with advanced cancers.

Portfolio Pulse from Vandana Singh

February 22, 2024 | 6:02 pm

ETH-USD

On Wednesday, 8,516.58 Ether (ETH) worth approximately $25.4 million was burned, permanently removing it from circulation. This action is part of the Ethereum blockchain's EIP-1159 upgrade implemented on August 5, 2021, which introduced a variable base fee for transactions that is burned. The current issuance rate of new Ether is 4% per year, expected to decrease to 0.5-1% with the Ethereum 2.0 upgrade, potentially making ETH a deflationary currency. The net annualized issuance rate for Ether was -9.51% yesterday.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 6:00 pm

CCL

CUK

NCLH

RCL

Cruise stocks are trading higher after Royal Caribbean Group announced an increase in its 2024 guidance, citing demand and bookings exceeding expectations. This positive outlook has influenced the broader cruise sector, including Carnival Corporation & plc and Norwegian Cruise Line Holdings Ltd.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 5:39 pm

AXSUSD

Luke Barwikowski, founder of Pixels, discusses the company's plan to revolutionize Web3 gaming, emphasizing seamless onboarding, strategic use of the Ronin Network, and community engagement through airdrops. The partnership with Binance Launchpool significantly increased daily active users, highlighting the importance of credible partnerships. Barwikowski envisions a future where Pixels leverages Web3 to enhance gaming and content monetization, with plans for multilingual support and the introduction of dungeons feature.

Portfolio Pulse from Jose Rodrigo Safdiye

February 22, 2024 | 5:33 pm

CAT

Caterpillar (NYSE:CAT) has seen significant options trading activity, with a bullish sentiment prevailing among investors. Analysis of 16 trades reveals 68% bullish and 31% bearish expectations. The trades focus on a price range of $310.0 to $480.0 for Caterpillar, with the largest trades being bullish calls and bullish puts. Caterpillar, a leading manufacturer of heavy equipment, is currently trading at $320.38, up 1.02%, with analysts giving mixed ratings but a consensus target price of $332.4.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 5:31 pm

MRK

MRNA

MYNZ

PFE

SGEN

Pfizer Inc (PFE) acquired Seagen Inc. (SGEN) to boost its oncology portfolio, aiming to add $25 billion to its annual revenue by the end of the decade. Moderna Inc (MRNA) and Merck & Co Inc (MRK) reported positive trial data for their melanoma cancer vaccine, showing significant reduction in death and recurrence risk. Mainz Biomed N.V. (MYNZ) announced a partnership for its colorectal cancer screening test, ColoAlert, with Europe's leading online medical retailer, aiming to improve early cancer detection.

Portfolio Pulse from Upwallstreet

February 22, 2024 | 5:21 pm